SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-001541
Filing Date
2024-01-18
Accepted
2024-01-18 18:01:27
Documents
1
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 form4-01182024_110120.html 4  
1 form4-01182024_110120.xml 4 4244
  Complete submission text file 0001415889-24-001541.txt   5662
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 630 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
WOODHOUSE DAVID J (Reporting) CIK: 0001642995 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 24543153